Nineteen monoclonal antibodies produced to dengue type 4 virus (DEN-4) strain 4328-S were tested for their ability to mediate antibody-dependent infection enhancement (ADE) with seven DEN-2 strains in P-388D1 mouse macrophage-like cells. In this first study of the distribution of enhancing epitopes on multiple DEN-2 strains reacted with monoclonal antibodies to a different serotype (DEN-4), DEN-4 monospecific antibodies produced ADE with DEN-2 viruses, indicating the presence of DEN-4-1ike determinants on DEN-2 viruses. Analysis differentiated at least one and possibly more DEN-2 strain subgroups, one of which (isolates AHF-110 and AHF-191) was previously identified by DEN-2 monoclonal antibody analysis. The study demonstrates the heterogeneous distribution of dengue complex and DEN-4 epitopes on DEN-2 strains. Monoclonal antibodies are valuable tools for study of the biology of ADE and its relation to dengue shock syndrome.
INTRODUCTION
Antibody-dependent enhancement (ADE) of virus infection has been demonstrated with four different RNA and two DNA virus families (Halstead, 1982) . The phenomenon, which occurs with sub-neutralizing antiviral IgG, results from the formation of virus-antibody complexes, attachment of complexes to cell Fc receptors (FcRs), and internalization by mononuclear phagocytes (Halstead, 1982) . It has been proposed that ADE is an important pathogenetic mechanism in severe and fatal dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS), which are linked to sequential infection with different dengue virus (DEN) serotypes after a critical time interval (Halstead, 1981 ; Sangkawibha et al., 1984) .
Dengue virus monoclonal antibodies provide a sensitive means of studying ADE: in previous investigations enhancement has been demonstrated when DEN-2 virus determinants were complexed by flavivirus group-, subgroup-or serotype-reactive DEN-2 monoclonal antibodies Halstead et al., 1984) . However, DHF occurs during infection with a second serotype: if ADE is involved, one or more antigenic determinants present on the first infecting serotype must elicit antibody that complexes with the same determinant on the second serotype. To identify antigenic and immunoreactive virus determinants mediating ADE on different DEN serotypes associated with naturally occurring sequential infections, we produced monoclonal antibodies to a DEN-4 strain recovered from the Southeast Asian haemorrhagic fever endemic area, and used them to probe determinants on seven DEN-2 strains by measuring the infectivity of monoclonal antibody-virus complexes for FcR-bearing macrophages.
METHODS
Virus strain used toproduce monoclonal antibodies. DEN-4 strain 4328-S was isolated in suckling mice from a 20 year old Filipino woman with an illness characterized as grade 11 DHF in 1966 (Halstead & Simasthien, 1970 stock prepared in 1975 in 50~ calf serum without gamma globulins, containing 1-7 × l0 s p.f.u, per ml in LLC-MK2 ceils (Morens et al., t985a) was used to make the antigens used for immunizing mice.
Preparation of immunogens. A mouse brain antigen was prepared by intracerebral inoculation of 2-day-old BALB/c mice using 0.02 ml of 4328-S tissue culture stock. Six days later, when all the mice were ill, brains were harvested, pooled and stored at -70 °C. The brains were later thawed, prepared as a 20~ suspension in TNE buffer (0-2 M-Tris-HCI pH 7.6, 0.15 M-NaC1, 0.003 M-EDTA) and centrifuged at 10000 r.p.m, for 1 h. The supernatant was then loaded onto a cushion of 35~o sucrose in TNE buffer and centrifuged 18 h at 25000 r.p.m, in a Beckman L2-65B ultracentrifuge. The pellet was reconstituted in 0-8 mI TNE buffer, and mixed with 0-8 ml complete Freund's adjuvant (lot R-096013, Gibco). Any preparation not used immediately was dispensed into vials and frozen at -70 °C.
A tissue culture antigen was prepared in monolayers of Igarashi's C6/36 clone of Aedes albopictus cells (Igara shi, 1978) grown in MEM with Earle's salts (Gibco) and 10~ foetal calf serum (FCS) in 32 oz glass prescription bottles and infected at an m.o.i, of 5.0 with DEN-4 strain 4328-S. Supernatants were collected on days 4 to 10, pooled, centrifuged for 30 min at 3000 r.p.m., filtered through a 0.45 p.m cellulose acetate filter (Nalgene, Nalge Company, Rochester, N.Y., U.S.A.), concentrated tenfold by hollow fibre ultrafiltration (Amicon CH4) and centrifuged for 1 h at 10000 r.p.m. The supernatant was then collected, loaded onto a 35 ~ (w/w) sucrose cushion in TNE buffer and centrifuged for 18 h at 25000 r.p.m. Sediment resuspended in TNE buffer was used both as a source of immunizing antigen and also for ELISA tests as described below.
Immunization schedule. Two 8-week-old BALB/c mice were inoculated intraperitoneally with 0.5 ml of mouse brain virus preparation on days 0, 44 and 68. On day 210 both mice received 0.2 ml of tissue culture antigen intravenously.
Fusion of mouse spleen cells and myeloma cells. Fusion was carried out by a modification of published methods Kearney et al., 1979) with spleens harvested from both BALB/c mice on day 212 of immunization. P3-X63-Ag8. 653 myeloma cells (Kearney et al., 1979) were added to immune spleen cells in equal volumes of medium containing 4.2 × 107 cells of each type. After fusion the cells were transferred in 100 ktl volumes to wells of 24-well polystyrene tissue culture plates (Corning) containing feeder layers of peritoneal monocytes from non-immune BALB/c mice at 1.0 x 104 cells per 0-4 ml per well. Plates were incubated at 37 °C under a 6~o COz atmosphere. Wells positive for hybridomas were screened for dengue virus antibody production by ELISA (see below); wells without visible hybridomas initially were re-examined at frequent intervals. Positive antibody-producing hybridomas were cloned twice by limiting dilution in 96-well polystyrene microtitre plates (Costar) containing feeder layers of 1.0 × 104 peritoneal macrophages from non-immune mice.
ELISA testing for screening and titre. ELISA antigen was produced by infection of Igarashi's C6/36 clone of Aedes albopictus cells (Igarashi, 1978) with DEN-4 strain 4328-S prepared as described above (see Preparation of immunogens).
Hybridomas were screened initially by addition of 50 ~tl supernatant fluid to wells of 96-weU polystyrene microtitre plates to which 1:40 dilutions of DEN-4 antigen had been adsorbed by incubation overnight at 4 °C in carbonate buffer of pH 9.6. Antibody was detected by visual inspection and grading (0 to 4 +) of the colour change associated with reaction of alkaline phosphatase-conjugated rabbit anti-mouse IgG (Miles Laboratories). Final ascitic fluid products (see below) were titrated by identical methods.
Ascitic fluid production. Normal adult BALB/c mice were injected intraperitoneally (i.p.) with Pristane (Pfaltz & Bauer, Stanford, Conn., U.S.A.) and I0 days later were injected i.p. with 1-0 x 107 hybridoma cells. Ascitic fluids were harvested when abdomens were protuberant, usually 10 to 14 days later.
Isotype characterization of DEN-4 monoclonal antibodies. Immunoglobulin isotype identifications were made using mouse ascitic fluid preparations and commercially available radial immunodiffusion plates (Meloy Laboratories, Springfield, Va., U.S.A.).
Virus strains. For neutralization (Nt) testing DEN-1 (16007), DEN-2 (16681), DEN-3 (16562), DEN-4 (4328-S) and Japanese encephalitis virus (JE, Nakayama strain) were used. For haemagglutination inhibition (HI) the following strains were used: DEN-1 (Hawaii), DEN-2 (New Guinea C), DEN-3 (H87), DEN-4 (H241) and JE (Nakayama). Seven DEN-2 strains (Table 1) were tested in ADE assays with DEN-4 monoclonal antibodies. The origin, year of isolation, and association with human disease of these strains has been reported previously (Halstead et al., 1984) . Strains originated from Southeast Asia, Oceania and the Caribbean. Three were isolated from patients with DSS and four from patients with uncomplicated dengue fever. All viruses were propagated one or more times in C6/36 cells and the same stock was used in all tests. Viruses were titrated in the BHK suspension plaque assay (Morens et al., 1985b) .
Neutralization and haemagglutination inhibition test of DEN-4 monoclonal antibodies. Nt tests on DEN-4 monoclonal antibodies were carried out by the 50~ plaque reduction endpoint method (PRNT) in the BHK cell suspension assay (Morens et al., 1985b) . HI tests were performed by the technique of Clarke & Casals (1958) adapted to micromethods, using trypsinized human group O erythrocytes as the reaction system, kaolin-treated mouse ascitic fluids adsorbed with human group O erythrocytes, and 8 units of sucrose-acetone-extracted mouse brain antigen. Assays for antibody-dependent enhancement of viral infection. ADE assays employed the P-388D1 mouse macrophage-like cell line (Halstead et al., 1983 (Halstead et al., , 1984 . In brief, DEN-2 virus strains at an m.o.i, of 0.05 were added to serial 10-fold dilutions (10 -2 to 10 -8) of ascitic fluid containing DEN-4 monoclonal antibodies and the mixtures added to dispersions of P-388D 1 cells in MEM-alpha medium (Gibco). Cells were grown in MEM-alpha with 10~
heat-inactivated FCS and antibiotics (Halstead et al., 1984) . Plates were incubated at 37 °C in 5 ~ CO2, harvested on days 4 (duplicate plate A) and 5 (duplicate plate B) by freezing at -70 °C, and titrated later as described (Morens et al., 1985b) . Replicate enhancement tests (one to five repeats) were performed for all antibody-virus combinations. The significance of difference in plaque counts within tests was determined by the method of Detre & White (1970) . Enhancement parameters recorded were peak-fold enhancement (PFE), i.e. the maximum ratio of p.f.u, per ml in wells containing virus pre-incubated with test antibody to those pre-incubated with dilutionmatched negative (control) antibody, and median enhancement titre, i.e. the median of all tested dilutions of ascitic fluids with which statistically significant enhancement was detected. When two peaks were observed, the lower of the two dilutions is reported.
RESULTS

Serological reactivity patterns
Nineteen monoclonal antibodies raised to DEN-4 strain 4328-S were serologically characterized by ELISA, HI and PRNT (Table 2 and 3) .Twelve were flavivirus group-reactive (UH-2B2, UH-2B4, UH-2C3, UH-3D1, UH-3D3, UH-5B3, UH-6B3-4, UH-5C1, UH-7D6, UH-8A1, UH-8C2 and UH-8D5-1), and seven were DEN-4 serotype-reactive (UH-3C5-BI, UH-5C3, UH-6C3, UH-6D3, UH-2A1, UH-8A4 and UH-8A6). The last-mentioned three reacted against DEN-4 antigen in the ELISA test, and are not necessarily DEN-4 ELISAspecific, whereas the first four of this group reacted with DEN-4 by Nt and/or HI. Dengue complex-reactive and subcomplex-reactive antibodies were not identified. For purposes of classification, the three monoclonal antibodies that reacted with DEN-4 by ELISA, but not Nt or HI, were tentatively assumed to be directed against non-envelope determinants, while the remaining antibodies, all of which had Nt activity, were assumed to react against envelope determinants.
Patterns of antibody activity by ADE
As shown in Table 4 , monoclonal antibodies reacted with the seven DEN-2 strains in 10 distinct patterns. Four flavivirus group-reactive monoctonal antibodies (UH-3D1, UH-6B3-4, UH-2B4 and UH-2C3) produced infection enhancement with all seven DEN-2 strains to antibody-related dilution endpoints which were similar (Pattern I). It is interesting to note that these four antibodies were the only flavivirus group-reactive antibodies with high DEN-4 HI titres (Table 2) . In a few instances, virus strain-dependent differences in PFE were marked (e.g. UH-6B3-4 and UH-2B4 compared to DEN-2 strain AHF-183, and UH-2B4 and UH-2C3 compared to DEN-2 AHF-191).
Two different groups of monoclonal antibodies each reacted with five of the DEN-2 viruses. There were three monoclonal antibodies (UH-7D6, UH-5B3 and UH-SA4) in Pattern II and two, UH-8C2 and UH-3C5-BI, in Pattern III. Since UH-8A4 did not neutralize DEN-4, whereas UH-7D6 and UH-5B3 did, possible differences in reactive sites were recognized, and these were designated as Patterns II and IIa. Table 3 . Table 4 .
Serological reactivities of 12 flavivirus group-reactive monoclonal antibodies raised to DEN-4 strain 4328-S in plaque reduction neutralization tests, haemagglutination inhibition tests and DEN-4 ELISA
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Serological reactivities of seven serotype-reactive monoclonal antibodies raised to DEN-4 strain 4328-S in plaque reduction neutralization tests, haemagglutination inhibition tests and DEN-4 ELISA
Identification of flavivirus group-specific and other determinants on seven dengue 2 strains by antibody dependent enhancement with single monoclonal antibody probes raised to dengue virus type 4
Virus strains Pattern III was composed of two monoclonal antibodies, one flavivirus group-reactive (UH-8C2) and the other DEN-4 serotype-reactive (UH-3C5-B1). To recognize the possibility that different epitopes were being identified, these antibodies were designated as Patterns III and IIIa.
Antibodies of Patterns IV and V each produced ADE with four different DEN-2 strains VI to IX with three strains, and Pattern X reacted with two DEN-2 strains. Despite its Nt activity (Table 2 ) UH-5C1 did not produce ADE with any of the seven strains. Pattern V had a flavivirus group-reactive and a DEN-4 serotype-reactive monoclonal antibody; these were separately designated V and Va. Table 5 arranges the seven DEN-2 strains by geographical origin, year of recovery, and distribution of enhancing epitopes as recognized by the 10 distinct monoclonal antibody reaction patterns. Two of the 1980 Thailand DEN-2 isolates (AHF-110 and AHF-191) had a similar distribution of enhancing epitopes (11 of 13 matches). Each of these DEN-2 strains had few sites that reacted with DEN-4 monoclonal antibody, lacking as many as 12 ADE sites identified on the other DEN-2 strains. The two Caribbean isolates, recovered at an interval of 18 years, were also similar (10 of 13 matches), as were two Thai strains (16681 and AHF-183) isolated at an interval of 16 years (nine of 13 matches). The Caribbean strains and Southeast Asian strains had multiple enhancement determinants, albeit with distinctive distribution patterns.
Patterns of DEN-2 virus reactivity with DEN-4-derived monoclonal antibodies
DISCUSSION
We produced 19 DEN-4 monoclonal antibodies, which are now added to the total of monoclonal antibodies raised to this immunogen . Previously reported dengue monoclonal antibodies, produced in secretor cells, include antibodies generated to DEN-3 of Dittmar and colleagues (1980, 1982) , which are not widely available, and DE N-2 serotype-reactive and cross-reactive antibodies made at the Walter Reed Army Institute of Research, which have been more completely characterized, distributed to investigators, and used for research and diagnosis Gentry et al., 1982; Gubler et al., 1984; Henchal et al., 1982 Henchal et al., , 1983 Henchal et al., , 1985 . This is the first study of antibody-dependent enhancement of DEN-2 virus infection using monoclonal antibodies raised against a dengue virus of another serotype (DEN-4) . This in vitro condition mimics that which occurs in natural secondary infections. In this study, DEN-4 monoclonal antibodies that were serotype-reactive in Nt and HI were able to enhance infection of DEN-2 viruses. Therefore, some DEN-2 strains must bear DEN-4-1ike epitopes, of possible relevance to the occurrence of cross-reactions between these serotypes in Nt analyses. Presumably such DEN-4-1ike determinants are sparsely distributed on DEN-2 virion surfaces, or are not intimately connected to 'critical sites' required for neutralization. It is more difficult to explain how monoclonal antibodies which do not appear to have envelope reactivity (e.g. UH-8A4) can mediate ADE. False positive reactions at the low dilutions are a possibility. Alternatively, the antibodies could actually be directed to structural epitopes that were not identified in Nt and HI, or were below the detection threshold, or they could be directed to nonenvelope determinants on immature particles, as reported by Henchal et al. (1985) for DEN-2 antibody 2H2. Why some antibodies with good Nt activity, e.g. UH-5C1, failed to mediate ADE is not known.
A previous study with the same seven DEN-2 strains and DEN-2 monoclonal antibodies (Halstead et al., 1984) suggested classification of the viruses into three groups (TR-1751/16681/AHF-183, AHF-110/AHF-191, and PR-159/New Guinea C). The present study also placed AHF-110 and AHF-191 in one determinant-specific group, but the other groupings based upon reactions with DEN-2 antibodies were not confirmed by reaction with the DEN-4 monoclonal antibodies. Undoubtedly, a much larger group of determinants is recognized by this set of DEN-4 monoclonal antibodies than the earlier, smaller set of DEN-2 antibodies, resulting in the recognition of additional differences in strains previously recognized by shared DEN-2-specific determinants.
The basis for differences in the magnitude of fold-enhancement is not known. Differences in antibody avidity could be one explanation: the more avid the reaction between antibody and virion (better complementarity between epitope and idiotype), the more complexes would be formed at any given concentration of antibody molecules. Alternatively, inherent differences in the ability of viruses to gain entry into cells could be magnified by antibody-dependent enhancement.
